Clinical Trial Update: Trial to Assess the Efficacy of Malaria Vaccine PfCS 102 [Phase 1, Phase 2]

View source ↗

Summary

PfCS 102 malaria vaccine trial has completed Phase 1 and Phase 2. The study was sponsored by the Swiss Tropical & Public Health Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• PfCS 102 vaccine (PfCS 102)

Snippet

Sponsor: Swiss Tropical & Public Health Institute | Conditions: Plasmodium Falciparum Malaria | Phase 1, Phase 2 | Status: COMPLETED